Page 302«..1020..301302303304..310320..»

Helixmith Announces Phase 3 Study Results of Novel Gene Therapy Treatment for Diabetic Foot Ulcers at 2021 Annual Meeting of Diabetic Foot Ulcer…

Posted: Published on October 24th, 2021

Data indicate that gene therapy appears to be effective, particularly in neuroischemic ulcers SAN DIEGO, Oct. 22, 2021 /PRNewswire/ -- Helixmith, a gene therapy company based in Seoul, Korea and San Diego, CA, announced today the results of a Phase 3 study for the treatment of diabetic foot ulcers with their novel gene therapy VM202 (Engensis) at the 2021 annual meeting of the Diabetic Foot Conference (DFCon) held in San Francisco and virtually. The study, "Gene Therapy for Diabetic Foot Ulcers: Analysis of a Randomized, Placebo-Controlled Phase 3 Study of Engensis (VM202), a Plasmid DNA Expressing Two Isoforms of Human Hepatocyte Growth Factor (HGF)," demonstrated a positive trend toward wound closure, potential healing effects and an acceptable safety profile Continue reading →

Posted in Hyperbaric Medicine | Comments Off on Helixmith Announces Phase 3 Study Results of Novel Gene Therapy Treatment for Diabetic Foot Ulcers at 2021 Annual Meeting of Diabetic Foot Ulcer…

Global Share of Oxygen Therapy Market (Equipment) to Rise at 8.3% CAGR, Will Reach USD 4.1 Billion by 2026 – GlobeNewswire

Posted: Published on October 24th, 2021

New York, NY, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled Oxygen Therapy Market By Product (Oxygen Source Equipment & Oxygen Delivery Devices), By Application (Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia, & Others), By End-User (Home Healthcare & Hospitals & Clinics), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026 in its research database According to the report, the globaloxygen therapy marketis predicted to be valued at approximately USD 2.7 Billion in 2020 and is expected to reach a value of around USD 4.1 Billion by 2026, at a CAGR of around 8.3% between 2021 and 2026. Global Oxygen Therapy Market: Overview Oxygen therapy is the process of delivering oxygen to a patient who has the ability to not retain the function of their lungs due to some accidental damage that has been caused to them. Continue reading →

Posted in Hyperbaric Medicine | Comments Off on Global Share of Oxygen Therapy Market (Equipment) to Rise at 8.3% CAGR, Will Reach USD 4.1 Billion by 2026 – GlobeNewswire

What is Ulcerative Colitis: Symptoms, Severity, and Treatment

Posted: Published on October 24th, 2021

Inflammation and your immune system Inflammation is your immune systems normal reaction to protect your body from bacteria, viruses, and other potentially harmful substances. However, for people with UC, the immune system is mistakenly triggered to attack the inner lining of the large intestine Continue reading →

Posted in Ulcerative Colitis | Comments Off on What is Ulcerative Colitis: Symptoms, Severity, and Treatment

Ulcerative colitis – Knowledge @ AMBOSS

Posted: Published on October 24th, 2021

Last updated: August 30, 2021 Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic mucosal inflammation of the rectum, colon, and cecum. Common symptoms include bloody diarrhea, abdominal pain, and fever. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Ulcerative colitis – Knowledge @ AMBOSS

ACG Clinical Guideline: Ulcerative Colitis in Adults …

Posted: Published on October 24th, 2021

Rubin, David T. MD, FACG1; Ananthakrishnan, Ashwin N. MD, MPH2; Siegel, Corey A. Continue reading →

Posted in Ulcerative Colitis | Comments Off on ACG Clinical Guideline: Ulcerative Colitis in Adults …

Stanford scientists link ulcerative colitis to missing gut …

Posted: Published on October 24th, 2021

Prior research has suggested, without much elaboration or follow-up, that secondary bile acids are depleted in ulcerative colitis patients and in those with a related condition, Crohns disease, in which tissue-destroying inflammation can occur in both the colon and the small intestine. The researchers confirmed that levels of the two most prominent secondary bile acids, deoxycholic acid and lithocholic acid, were much lower in stool specimens taken from the ulcerative colitis pouch patients than from FAP pouch patients. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Stanford scientists link ulcerative colitis to missing gut …

Ulcerative colitis clinical trials: What to know – Medical News Today

Posted: Published on October 24th, 2021

Ulcerative colitis is a form of inflammatory bowel disease. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Ulcerative colitis clinical trials: What to know – Medical News Today

Geriatric ulcerative colitis: Treatment, complications, and more – Medical News Today

Posted: Published on October 24th, 2021

Ulcerative colitis (UC) among older adults is becoming more and more common. Geriatric UC can emerge at an older age, or it can start when someone is younger and continue throughout their life Continue reading →

Posted in Ulcerative Colitis | Comments Off on Geriatric ulcerative colitis: Treatment, complications, and more – Medical News Today

Can you fly with ulcerative colitis? What to know. – Medical News Today

Posted: Published on October 24th, 2021

Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) that can cause symptoms such as abdominal pain and diarrhea. Although the condition can make traveling more difficult, preparation can help Continue reading →

Posted in Ulcerative Colitis | Comments Off on Can you fly with ulcerative colitis? What to know. – Medical News Today

Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China – PRNewswire

Posted: Published on October 24th, 2021

SEONGNAM, South Korea and CHENGDU, China, Oct. 19, 2021 /PRNewswire/ --Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company focused on developing novel drugs for inflammation, fibrosis and oncology, announced that the first subject has been dosed in the China Phase I clinical trial of BBT-401, a small molecule inhibitor of Pellino-1, which is believed to play a significant role in inflammatory signaling pathways Continue reading →

Posted in Ulcerative Colitis | Comments Off on Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China – PRNewswire

Page 302«..1020..301302303304..310320..»